| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | G4990BOZ66 |
| InChI Key | RWEVIPRMPFNTLO-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C16H17FIN3O4 |
| Molecular Weight | 461.23 |
| AlogP | 1.83 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 92.59 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 25.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Dual specificity mitogen-activated protein kinase kinase 1 inhibitor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Kinase
Protein Kinase
Other protein kinase group
Other protein kinase PEK family
Other protein kinase HRI
|
- | - | 1821 | - | - | |
|
Enzyme
Kinase
Protein Kinase
STE protein kinase group
STE protein kinase STE7 family
|
- | 7 | 15 | - | - | |
|
Enzyme
Transferase
|
- | - | - | - | 9.899 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | 1.05-7.79 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 91424 |
| ChEMBL | CHEMBL3182621 |
| DrugBank | DB06061 |
| EPA CompTox | DTXSID50235986 |
| FDA SRS | G4990BOZ66 |
| Guide to Pharmacology | 8474 |
| PubChem | 16666708 |
| SureChEMBL | SCHEMBL388533 |
| ZINC | ZINC000043152942 |